Inhibitory Antibodies
-
F1585 Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab)Summary: Anti-Integrin b2/ITGB2/CD18 Antibody (Erlizumab) -
F1586 Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab)Summary: Anti-Integrin a5b1 (ITGA5 & ITGB1) Antibody (Volociximab) -
F1587 Anti-GPR44/PTGDR2/CD294 Antibody (KHK patent anti-CRTH2)Summary: Anti-GPR44/PTGDR2/CD294 Antibody (KHK patent anti-CRTH2) -
F1588 Anti-Histone H3 Antibody (Immunomedics patent anti-Histone H3)Summary: Anti-Histone H3 Antibody (Immunomedics patent anti-Histone H3) -
F1589 Anti-OX2R/CD200R1 Antibody (Janssen patent anti-CD200R1)Summary: Anti-OX2R/CD200R1 Antibody (Janssen patent anti-CD200R1) -
F1590 Anti-PAR2 Antibody (PAR650097)Summary: Anti-PAR2 Antibody (PAR650097) -
F1591 Anti-Integrin aL/ITGAL/CD11a Antibody (Efalizumab)Summary: Anti-Integrin aL/ITGAL/CD11a Antibody (Efalizumab) -
F1592 Anti-CD79b Antibody (IladatuzumAb)Summary: Anti-CD79b Antibody (IladatuzumAb) -
F1593 Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab)Summary: Anti-F3/Factor III/Tissue Factor/CD142 Antibody (Tisotumab) -
F1594 Anti-CD20 Antibody (Veltuzumab)Summary: Anti-CD20 Antibody (Veltuzumab)